Stevens–Johnson syndrome

Results: 53



#Item
31The Treatment of Toxic Epidermal Necrolysis (TEN) in North America Roni P. Dodiuk-Gad, Robert Cartotto, Marc Jeschke, Joel Fish, Neil H. Shear (CDA Member sponsor) Division of Dermatology & Ross Tilley Burn Centre Sunnyb

The Treatment of Toxic Epidermal Necrolysis (TEN) in North America Roni P. Dodiuk-Gad, Robert Cartotto, Marc Jeschke, Joel Fish, Neil H. Shear (CDA Member sponsor) Division of Dermatology & Ross Tilley Burn Centre Sunnyb

Add to Reading List

Source URL: www.dermatology.ca

Language: English - Date: 2014-06-09 11:19:46
32Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Analysis of Triggers

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Analysis of Triggers

Add to Reading List

Source URL: www.dermatology.ca

Language: English - Date: 2014-06-09 11:19:50
33SULFONAMIDE CROSS-REACTIONS EXPLAINED

SULFONAMIDE CROSS-REACTIONS EXPLAINED

Add to Reading List

Source URL: medsask.usask.ca

Language: English - Date: 2013-03-14 12:11:16
34Tamiflu® (oseltamivir) Background Information and Drug Utilization Patterns Pediatric Advisory Committee Meeting May 7, 2012 Amy M. Taylor, MD, MHS

Tamiflu® (oseltamivir) Background Information and Drug Utilization Patterns Pediatric Advisory Committee Meeting May 7, 2012 Amy M. Taylor, MD, MHS

Add to Reading List

Source URL: www.fda.gov

Language: English
35NDA[removed]S-107 NDA[removed]S-055 NDA[removed]S-048 NDA[removed]S-040 FDA Approved Labeling Text dated[removed]Page 1

NDA[removed]S-107 NDA[removed]S-055 NDA[removed]S-048 NDA[removed]S-040 FDA Approved Labeling Text dated[removed]Page 1

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-12-13 15:46:33
36[removed]Summary AR lamotrigine

[removed]Summary AR lamotrigine

Add to Reading List

Source URL: www.hma.eu

Language: English - Date: 2014-05-06 06:23:36
37FDA Drug Safety Communication: FDA warns of serious skin reactions with the anti-seizure drug Onfi (clobazam) and has approved label changes Safety Announcement[removed]The U.S. Food and Drug Administration (FDA) is

FDA Drug Safety Communication: FDA warns of serious skin reactions with the anti-seizure drug Onfi (clobazam) and has approved label changes Safety Announcement[removed]The U.S. Food and Drug Administration (FDA) is

Add to Reading List

Source URL: www.fda.gov

Language: English
38•	 History of serious hypersensitivity reaction (e.g., Stevens-Johnson syndrome, anaphylactic reaction, angioedema) to carvedilol or any of the components of COREG CR. (4) ----------------------- WARNINGS AND PRECAUTIO

• History of serious hypersensitivity reaction (e.g., Stevens-Johnson syndrome, anaphylactic reaction, angioedema) to carvedilol or any of the components of COREG CR. (4) ----------------------- WARNINGS AND PRECAUTIO

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-07-07 14:38:57
39NDA[removed]S-032 NDA[removed]S-035 FDA Approved Labeling Text dated[removed]Page 1  CARBATROL®

NDA[removed]S-032 NDA[removed]S-035 FDA Approved Labeling Text dated[removed]Page 1 CARBATROL®

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2013-03-26 13:25:12
40•	 History of serious hypersensitivity reaction (e.g., Stevens-Johnson syndrome, anaphylactic reaction, angioedema) to carvedilol or any of the components of COREG CR. (4) ----------------------- WARNINGS AND PRECAUTIO

• History of serious hypersensitivity reaction (e.g., Stevens-Johnson syndrome, anaphylactic reaction, angioedema) to carvedilol or any of the components of COREG CR. (4) ----------------------- WARNINGS AND PRECAUTIO

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-01-31 14:17:54